六国化工(600470) - 2019 Q3 - 季度财报

Financial Performance - Operating revenue increased by 11.74% to CNY 3,204,318,329.30 for the period from January to September[7] - Net profit attributable to shareholders of the listed company decreased by 396.13% to a loss of CNY 47,950,752.65[7] - Basic earnings per share decreased by 71.43% to CNY 0.02[8] - The company reported a significant investment loss of ¥655,295,280.90 in Q3 2019, impacting overall financial performance[26] - Net profit for Q3 2019 was a loss of ¥31,127,447.93, compared to a profit of ¥10,427,074.87 in Q3 2018, representing a significant decline[27] - The total comprehensive income for Q3 2019 was a loss of ¥31,127,447.93, compared to a profit of ¥10,427,074.87 in Q3 2018[28] - The net profit for Q3 2019 was -25,383,914.89 RMB, a significant decrease compared to a profit of 35,320,461.32 RMB in Q3 2018, representing a decline of approximately 172%[30] - Total profit for Q3 2019 was a loss of ¥31,168,048.67, compared to a profit of ¥13,612,517.22 in Q3 2018[27] Cash Flow - The net cash flow from operating activities improved significantly to CNY 273,804,925.43, compared to a loss of CNY 240,226,433.76 in the same period last year[7] - Cash flow from operating activities for the first nine months of 2019 was 273,804,925.43 RMB, a recovery from a negative cash flow of -240,226,433.76 RMB in the same period of 2018[34] - Cash flow from investing activities for the first nine months of 2019 was -126,463,866.88 RMB, an improvement from -292,916,160.96 RMB in the same period of 2018[35] - Cash flow from financing activities for the first nine months of 2019 was -295,746,708.54 RMB, compared to a positive cash flow of 761,142,587.32 RMB in the same period last year, indicating a shift of approximately 138.8%[35] - Cash inflow from financing activities decreased to ¥704,000,000.00 in 2019 from ¥1,014,000,000.00 in 2018, a decline of approximately 30.6%[37] - Cash outflow from financing activities increased to ¥812,827,447.08 in 2019 from ¥566,206,759.00 in 2018, an increase of about 43.5%[37] Assets and Liabilities - Total assets decreased by 10.25% to CNY 5,174,482,813.90 compared to the end of the previous year[7] - The company’s total liabilities decreased to ¥3,142,867,019.33 from ¥3,665,008,713.50[17] - Total liabilities reached ¥1,882.45 million, an increase from ¥1,804.19 million in the previous year, indicating a rise of about 4.3%[22] - The company's total equity decreased to ¥1,611.16 million from ¥1,661.87 million, representing a decline of approximately 3.0%[22] - The total assets as of the end of the reporting period were ¥5,765,438,140.20, unchanged from the previous year[40] - Total liabilities amounted to ¥4,382,379,270.33, with current liabilities at ¥3,665,008,713.50 and non-current liabilities at ¥717,370,556.83[41] Shareholder Information - The total number of shareholders at the end of the reporting period was 42,355[10] - The largest shareholder, Tongling Chemical Industry Group Co., Ltd., holds 25.49% of the shares[10] Research and Development - Research and development expenses surged by 869.86% to ¥46,852,211.84 compared to the same period last year[14] - Research and development expenses for Q3 2019 were ¥13,233,555.01, a substantial increase from ¥1,723,601.67 in Q3 2018[26] Government Support - Government subsidies recognized during the period amounted to CNY 13,953,494.48[8] - Deferred income increased by 59.07% to ¥180,072,408.75 due to an increase in government grants related to assets[12]